Clinical trials using MDMA (Ecstasy) to treat Post-Traumatic Stress Disorder (PTSD) are showing positive results in controlled therapeutic settings. The FDA is overseeing studies where soldiers and other trauma survivors use the drug to facilitate therapy. One host jokes about having PTSD to justify trying the substance, while the other warns about the potential for brain damage.
